Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2021/167389
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing a mTOR-signaling inhibitor as an active ingredient. The composition of the present invention exhibits the efficacy of inhibiting the growth of cancer cells and killing cancer cells, and thus can be used as an anticancer agent.

Inventors:
KIM SEYUN (KR)
LEE BOAH (KR)
PARK SEUNG JU (KR)
Application Number:
PCT/KR2021/002105
Publication Date:
August 26, 2021
Filing Date:
February 19, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOREA ADVANCED INST SCI & TECH (KR)
International Classes:
A61K31/4468; A61P35/00; A61P35/02
Domestic Patent References:
WO1998003174A11998-01-29
Foreign References:
US20140171456A12014-06-19
US20180125812A12018-05-10
KR20190139637A2019-12-18
KR20200021549A2020-02-28
Other References:
HUA HUI, KONG QINGBIN, ZHANG HONGYING, WANG JIAO, LUO TING, JIANG YANGFU: "Targeting mTOR for cancer therapy", JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 12, no. 71, 1 December 2019 (2019-12-01), pages 1 - 19, XP055839513, DOI: 10.1186/s13045-019-0754-1
"Remington's Pharmaceutical Sciences", 1995
See also references of EP 4108242A4
Attorney, Agent or Firm:
KONG, Byung Wook (KR)
Download PDF: